アクセリードとA2ヘルスケア、日本での医薬品R&Dで提携
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership. This deal aims to speed up drug research and development in Japan. This partnership combines the strengths of both organizations. It creates a complete support system for drug development, from discovery to manufacturing. Axcelead works worldwide, focusing on drug discovery services and mRNA contract development and manufacturing (CDMO). Axcelead Drug Discovery Partners, Inc. delivers its drug discovery expertise. (Fujisawa City, Kanagawa) and Axcelead Tokyo West Partners, Inc. (Hino City, Tokyo), both offering pharmaceutical-grade platforms. Additionally, its subsidiary ARCALIS, Inc. Minamisoma City, Fukushima, has Asia-Pacific’s first GMP-compliant API manufacturing facility. It focuses on mRNA vaccines and therapeutics. A2 Healthcare is a full-service contract research organization (CRO). They provide clinical development solutions for both pharmaceuticals and medical devices. The company…
